#USA #New York #Class Action #Faruqi & Faruqi #Zynex

Faruqi & Faruqi Issues Important Reminder to Zynex Investors

Introduction
Faruqi & Faruqi, LLP, a prominent national securities law firm, has recently issued a crucial reminder to investors in Zynex, Inc., also known by its stock ticker symbol ZYXIQ. This reminder pertains to the ongoing federal securities class action and highlights the urgent deadline of April 21, 2026, for potential lead plaintiffs wishing to participate in the case.

Overview of Zynex Class Action
Zynex has been under scrutiny for its business practices, which come to light through allegations made in the pending class action lawsuit. The case alleges that Zynex and its top executives engaged in deceptive practices that led to inflated revenue and potential civil penalties. As part of the investigation, Faruqi & Faruqi contend that Zynex's misleading statements have caused harm to investors who bought or acquired the company's securities between February 25, 2021, and December 15, 2025.

Key Allegations against Zynex
Investigators from Faruqi & Faruqi have detailed a series of allegations that raise significant concerns about Zynex's compliance with federal securities laws:
1. Inflated Revenue Reporting: Zynex is accused of shipping more products than necessary, which created artificial revenue growth.
2. Insurance Scrutiny: The company's billing practices have drawn the attention of insurers, leading to investigations and lawsuits.
3. Fraudulent Overbilling Claims: A lawsuit brought against Zynex alleges a fraudulent overbilling scheme, during which the company allegedly submitted hundreds of false claims worth over $23 million.
4. Prioritization of Sales Over Compliance: There are claims that Zynex's management neglected critical regulatory compliance in favor of aggressive sales tactics.
5. Poor Internal Controls: Zynex has been criticized for not maintaining adequate internal controls, leading to questionable business practices.

These allegations took a toll on Zynex's stock price. Notably, in March 2025, upon revealing a significant revenue shortfall due to payment delays from payers, Zynex's shares plummeted by over 51%. Furthermore, as news of non-compliance with industry regulations broke, Zynex's stock fell again, showcasing the concerning nature of the enterprise's business practices.

Opportunities for Investors
The law firm encourages any Zynex investor who may have suffered financial losses to reach out and explore their legal rights. Prospective lead plaintiffs must act quickly, as the deadline for filing is set for April 21, 2026, and it is essential for investors to understand how the class action may impact their interests.

Investors who wish to maintain the right to recover damages under the federal securities laws should consider reaching out to Josh Wilson, a partner at Faruqi & Faruqi. Engaging with the law firm could provide clarity and direction regarding the next steps.

Next Steps for Interested Investors
Interested parties can learn more and ensure they are informed about their rights as potential participants in this class action. Faruqi & Faruqi suggests that anyone with inside knowledge about Zynex, including whistleblowers, former employees, or even current investors, should contact the firm for a confidential consultation.

As we move closer to the critical deadline, constant updates and additional information will be made available through Faruqi & Faruqi's website. Investors are encouraged to remain apprised of developments related to the case.

Conclusion
With the April 21, 2026 deadline encroaching, Zynex investors should reconsider their positions and take appropriate action regarding their legal rights. The unfolding litigation represents a pivotal moment for many who have believed in Zynex’s potential and faced unfortunate consequences due to alleged deceptive practices. If you're an investor in Zynex, this is the time to stay informed and seek the assistance of experienced legal professionals.

For further inquiries or detailed information on the Zynex class action, please visit Faruqi & Faruqi's website or get in touch directly with Joshua Wilson at 877-247-4292.

Stay tuned for updates and ensure your interests are protected in this ongoing case.